Financials
- Market Capitalization 9.22 B
- Employee 253
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-23.27
Rapporto prezzo/fatturato
148.57
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 925 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | +0.02% | +0.18% | +0.45% | +30.55% | 9.79 B USD | ||
| 930 | CORT Corcept Therapeutics Incorporated - Common Stock | 90.47 USD | +5.32% | -2.47% | +8.76% | +23.31% | 9.71 B USD | ||
| 959 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 327.68 USD | +4.17% | +1.30% | +23.69% | +529.19% | 9.14 B USD | ||
| 966 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 54.93 USD | -3.21% | -35.80% | -25.70% | -23.84% | 9.08 B USD |